FindTrial
Sign In

Abberant expression of peripheral microRNA in general anxiety disorder and its clinical application study

Abberant expression of peripheral microRNA in general anxiety disorder and its clinical application study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-13003210
Enrollment
Unknown
Registered
2013-05-06
Start date
2013-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anxiety Disorder

Interventions

GAD group:medication
GAD control group:observation
fully recovered group:medication
efficient group:medication
improved group:medication
invalid group:medication

Sponsors

102th Hospital of Chinese People’s Liberation Army, Clinical Hospital of Mental health affiliated to the Second Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: In accord with DSM-?; No history of blood transfusion one month before inclusion; No history of anti-psychotic medication three months before inclusion

Exclusion criteria

Exclusion criteria: With history of brain trauma or other neurological diseases; With history of severe neurological dysfunction, affective disorder, or mental retardation; With history of severe alcoholic problem or drug abuse.

Design outcomes

Primary

MeasureTime frame
microRNA;—

Countries

China

Contacts

Public ContactLi-yi Zhang
zly102@126.com+86 519-83064556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026